COMMUNIQUÉS West-GlobeNewswire

Trading in GN Store Nord shares by board members, executives and associated persons
25/08/2026
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Astrocyte Pharmaceuticals Receives NIH Award to Evaluate AST-004 in Substance Use Disorders
25/08/2026
$400,000 program extends AST-004 into another major CNS indication and reinforces the breadth of its cerebroprotective potential GROTON, Conn., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc. , a [...]
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
25/08/2026
Beyond Air to receive shares representing 19.99% of Univo's issued and outstanding share capital upon closing Beyond Air eligible to receive up to $32.5 million in development and commercial milestone payments GARDEN [...]
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
25/08/2026
CAMBRIDGE, Mass., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by [...]
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
25/08/2026
BETHESDA, Md., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain” or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
Immatics Announces $150 Million Underwritten Offering
25/08/2026
Houston, Texas and Tuebingen, Germany, August 25, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell [...]
Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
25/08/2026
ATLANTA, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 2026 Jefferies Healthcare Services and Technology [...]
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
25/08/2026
RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, announced today that Caitlin Zulla [...]
BrewDog Wins Big at the 2026 World Beer Awards with a Sweeping Show of Brewing Excellence
25/08/2026
Hazy Jane, Wingman and Mackie’s Two Scoops Earn Gold and Scotland Country Winner Awards, with Punk IPA, Lost Lager, Black Heart and Mello Also Recognised Among the World’s Best Beers ELLON, Scotland and LONDON, Aug. 25 [...]
Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026
25/08/2026
All clinical trial sites identified and CRO retained Patient screening expected to begin in October 2026, with first patient to be enrolled shortly after FOSTER CITY, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Sagimet [...]
Apollo Therapeutics Announces Positive Immunogenicity Data and Cross-Species Activity from Phase 1 Trial of APL-10456, a Pan-Rhinovirus Vaccine for the Prevention of COPD Exacerbations
25/08/2026
Enrollment and dosing completed in Phase 1 randomized controlled trial (n=144) evaluating the safety, tolerability, immunogenicity and cross-species activity of APL-10456, an investigational rhinovirus vaccine Initial [...]
BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan
25/08/2026
— Expands availability of the first and only oral prophylactic therapy for patients with HAE ages 2 to <12 years in Japan — RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, [...]
SERB Applauds Publication of Consensus Statements and Recommendations for Neuroblastoma Care in Pediatric Blood & Cancer
25/08/2026
Multidisciplinary panel publishes 30 consensus statements to improve communication and shared decision-making in neuroblastoma care WEST CONSHOHOCKEN, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a [...]
Ocugen to Participate in Upcoming September Investor and Industry Conferences
25/08/2026
MALVERN, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will [...]
OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations
25/08/2026
Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology WARSAW, Ind., Aug. 25, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics) (Nasdaq: KIDS), a company [...]
Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium
25/08/2026
Presentation addressed potential applications in prolonged field care and military wound management settings WINNIPEG, Manitoba, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or [...]
Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium
25/08/2026
Presentations from U.S. and German early access programs highlight sustained disease stabilization and a consistent safety profile across diverse NPC patient populations BOSTON, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Zevra [...]
Annovis to Host Corporate Update Webinar on September 2, 2026
25/08/2026
MALVERN, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
25/08/2026
TAIPEI, Taiwan, Aug. 25, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic [...]

Pages